Koyfin Home > Directory > Health Care > Acorda Therapeutics > Price / Earnings (ntm)

Acorda Therapeutics Price / Earnings (ntm) Chart (ACOR)

Acorda Therapeutics annual/quarterly Price / Earnings (ntm) from 2010 to 2018. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Acorda Therapeutics Price / Earnings (ntm) for the quarter ending February 02, 2018 was 278.89 a 96.27% increase of 268.50 year over year
  • Acorda Therapeutics Price / Earnings (ntm) for the last 12 months ending February 02, 2018 was 278.89 a 96.27% increase of 268.50 year over year
  • Acorda Therapeutics Annual Price / Earnings (ntm) for 2018 was 278.89 a 96.15% increase of 268.14 from 2017
  • Acorda Therapeutics Annual Price / Earnings (ntm) for 2018 was 10.75 a 2.54% increase of 0.27 from 2017
  • Acorda Therapeutics Annual Price / Earnings (ntm) for 2018 was 10.47 a 0.80% increase of 0.08 from 2017
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.11 a 35.48% increase of 0.75 year over year
  • Acorda Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $1,138m a 2.19% increase of 25m year over year
View Chart On Koyfin

Quarterly ACOR Price / Earnings (ntm) Data

02/2018278.89
02/201810.75
02/201810.47
02/201810.39
02/201810.10
02/201810.01
02/201810.56
02/201810.45
02/201810.05
02/201810.62

Annual ACOR Price / Earnings (ntm) Data

2018278.89
201810.75
201810.47
201810.39
201810.10
201810.01
201810.56
201810.45
201810.05
201810.62